Abstract
The development of new antimicrobial agents has fallen behind microbial drug resistance, posing a significant challenge for combating infectious disease. Nanotherapeutics have revolutionized antimicrobial therapy, providing new mechanisms to combat microbial resistance. Nitric oxide (NO), a simple gaseous molecule with ubiquitous biological activity, represents one such strategy as its antimicrobial properties are well described. Harnessing this potential has proven difficult given the lack of effective delivery vehicles. However, this challenge has been overcome by the generation of a nanoparticulate system capable of generating physiologic concentrations of NO over time. The efficacy of these platforms against bacteria and fungi has been shown in a variety of studies. Here, we review the role of NO-releasing nanoparticulate platforms as an antimicrobial therapeutic agent.
| Original language | English (US) |
|---|---|
| Title of host publication | Nanoscience in Dermatology |
| Publisher | Elsevier Inc. |
| Pages | 127-134 |
| Number of pages | 8 |
| ISBN (Electronic) | 9780128029459 |
| ISBN (Print) | 9780128029268 |
| DOIs | |
| State | Published - Aug 25 2016 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Antimicrobial
- Nanoparticles
- Nanotechnology
- Nitric oxide
- Nitric-oxide releasing platforms
- Novel therapeutics
ASJC Scopus subject areas
- General Medicine
Fingerprint
Dive into the research topics of 'Nitric Oxide-Releasing Nanoparticles as an Antimicrobial Therapeutic'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS